Amyloid formation under physiological conditions proceeds via a native-like folding intermediate
暂无分享,去创建一个
M. J. Parker | Sheena E Radford | S. Radford | S. Homans | T. Jahn | Steve W Homans | Martin J Parker | Thomas R Jahn
[1] F. Hartl,et al. Roles of molecular chaperones in protein misfolding diseases. , 2004, Seminars in cell & developmental biology.
[2] C. Robinson,et al. Removal of the N‐terminal hexapeptide from human β2‐microglobulin facilitates protein aggregation and fibril formation , 2000, Protein science : a publication of the Protein Society.
[3] Kevin W. Plaxco,et al. The importance of being unfolded , 1997, Nature.
[4] Christopher M. Dobson,et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.
[5] Henry A. Lester,et al. Cis–trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel , 2005, Nature.
[6] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[7] M. R. Nilsson. Techniques to study amyloid fibril formation in vitro. , 2004, Methods.
[8] C. Dobson,et al. A Partially Structured Species of β2-Microglobulin Is Significantly Populated under Physiological Conditions and Involved in Fibrillogenesis* , 2001, The Journal of Biological Chemistry.
[9] C. Ionescu-Zanetti,et al. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. , 2001, Biochemistry.
[10] Jennifer Stine Elam,et al. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS , 2003, Nature Structural Biology.
[11] Sheena E Radford,et al. The Yin and Yang of protein folding , 2005, The FEBS journal.
[12] Satoru Suzuki,et al. Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro , 1997 .
[13] J. Kelly,et al. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation. , 1998, Biochemistry.
[14] Andreas Martin,et al. Prolyl isomerization as a molecular timer in phage infection , 2005, Nature Structural &Molecular Biology.
[15] C. Anfinsen. Principles that govern the folding of protein chains. , 1973, Science.
[16] Role of the N and C-terminal strands of beta 2-microglobulin in amyloid formation at neutral pH. , 2003, Journal of molecular biology.
[17] Tony Hunter,et al. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration , 2003, Nature.
[18] C. Dobson. Protein folding and misfolding , 2003, Nature.
[19] J. Richardson,et al. Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[20] F. Gejyo,et al. Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. , 1986, The New England journal of medicine.
[21] F. Gejyo,et al. Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. , 2004, Journal of the American Society of Nephrology : JASN.
[22] S. Radford,et al. A systematic study of the effect of physiological factors on beta2-microglobulin amyloid formation at neutral pH. , 2006, Biochemistry.
[23] Lisa J. Lapidus,et al. Measuring the rate of intramolecular contact formation in polypeptides. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[24] David Eisenberg,et al. Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure , 2005, Nature.
[25] T. Yeates,et al. Arrangement of subunits and ordering of beta-strands in an amyloid sheet. , 2002, Nature structural biology.
[26] C. Dobson,et al. Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin. , 2001, Journal of molecular biology.
[27] Michele Vendruscolo,et al. Towards complete descriptions of the free–energy landscapes of proteins , 2005, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[28] D. Wemmer,et al. A glimpse of a possible amyloidogenic intermediate of transthyretin , 2000, Nature Structural Biology.
[29] Christopher M. Dobson,et al. The protofilament structure of insulin amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Radford,et al. Structural properties of an amyloid precursor of beta(2)-microglobulin. , 2002, Nature structural biology.
[31] Acquisition of native beta-strand topology during the rapid collapse phase of protein folding. , 1997, Biochemistry.
[32] S. Radford,et al. Crystal structure of monomeric human β-2-microglobulin reveals clues to its amyloidogenic properties , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[33] A. Corazza,et al. The solution structure of human β2‐microglobulin reveals the prodromes of its amyloid transition , 2002, Protein science : a publication of the Protein Society.
[34] J. Kelly,et al. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. , 1998, Current opinion in structural biology.
[35] Peter Chien,et al. Emerging principles of conformation-based prion inheritance. , 2004, Annual review of biochemistry.
[36] A. Andreotti,et al. Structural characterization of a proline-driven conformational switch within the Itk SH2 domain , 2002, Nature Structural Biology.
[37] M. Gruebele. Protein folding: the free energy surface. , 2002, Current opinion in structural biology.
[38] Christopher M. Dobson,et al. Kinetic partitioning of protein folding and aggregation , 2002, Nature Structural Biology.
[39] H. Wolfson,et al. Beta2-microglobulin amyloidosis: insights from conservation analysis and fibril modelling by protein docking techniques. , 2003, Journal of molecular biology.
[40] Bruce A. Johnson,et al. NMR View: A computer program for the visualization and analysis of NMR data , 1994, Journal of biomolecular NMR.
[41] Min Goo Lee,et al. A protein sequence that can encode native structure by disfavoring alternate conformations , 2002, Nature Structural Biology.
[42] D A Smith,et al. Beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. , 2001, Journal of molecular biology.
[43] A. Kameda,et al. Nuclear magnetic resonance characterization of the refolding intermediate of beta2-microglobulin trapped by non-native prolyl peptide bond. , 2005, Journal of molecular biology.
[44] V. Uversky,et al. Conformational constraints for amyloid fibrillation: the importance of being unfolded. , 2004, Biochimica et biophysica acta.
[45] R. Wetzel,et al. Conformational Abs recognizing a generic amyloid fibril epitope , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[46] S. Radford,et al. Dynamics in the unfolded state of beta2-microglobulin studied by NMR. , 2005, Journal of molecular biology.
[47] S. Grzesiek,et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.
[48] J. Kelly,et al. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. , 1992, Biochemistry.
[49] C. Dobson,et al. Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. , 2005, Biophysical journal.